TY  - RPRT
TI  - Integrating Phase 2 into Phase 3 based on an Intermediate Endpoint While Accounting for a Cure Proportion -- with an Application to the Design of a Clinical Trial in Acute Myeloid Leukemia
AU  - Kaspar Rufibach
AU  - Dominik Heinzmann
AU  - Annabelle Monnet
PY  - 2019
DO  - 10.1002/pst.1969
UR  - https://arxiv.org/abs/1901.01308
ID  - 1901.01308
ER  -